Immunogen Inc. (IMGN) PT Raised to $25 at Canaccord Genuity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Join SI Premium – FREE
Canaccord Genuity analyst John Newman raised the price target on Immunogen Inc. (NASDAQ: IMGN) to $25.00 (from $23.00) while maintaining a Buy rating.
You May Also Be Interested In
- EverQuote (EVER) PT Raised to $35 at B.Riley, 'we continue to find the risk/reward attractive'
- Netskope (NTSK) PT Raised to $30 at BTIG
- Marriott International (MAR) PT Raised to $463 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
